Responsibilities:
- Serve as a key medical scientific expert contributing to development and review of educational content across transplant indications; ensure consistent therapeutic area messaging and adherence to established standards.
- Collaborate with cross-functional partners (Clinical Development, Value & Access, Commercialization, Affiliate Medical Affairs) as a subject matter expert to support strategic medical initiatives, including protocol review, scientific resource development, evidence generation, and internal training materials.
- Develop and execute medical advisory boards with GMA transplant team members.
- Support development of the annual medical strategic plan aligned with Medical Affairs leadership objectives.
- Lead or support execution of evidence generation activities.
- Attend major scientific congresses and conferences to gather clinical insights, assess emerging data, and support conference coverage materials and internal training.
- Coordinate and implement GMA transplant team initiatives with cross-functional stakeholders.
Qualifications / Required Skills:
- PharmD, PhD, MD, DNP, or other advanced degree in the life sciences.
- Minimum 5 yearsβ experience in the pharmaceutical industry (ideally Medical Affairs); combination of relevant clinical/research and pharmaceutical experience may be considered.
- Solid organ transplant therapeutic area expertise.
- Excellent communication (written and oral), including presentation skills.
- Strong interpersonal skills; ability to operate and exert influence in a highly matrixed organization.
- Solid project management skills; ability to take initiative to solve complex problems.
Benefits (if applicable):
- Medical, Dental, Vision, & Life insurances; Fitness & Wellness programs; Short- and Long-Term Disability insurance; paid vacation and end-of-year shutdown; company paid holidays; sick time; Paid Maternity and Parental Leave; 401(k) with company match; employee stock purchase plan; tuition reimbursement (up to $10,000/year); Employee Resource Groups participation.